Guardant Health
GH
145.83
+0.24
+0.16%
Guardant Health
US · GH
#820 by market cap
Listed 2018
145.83
+0.24
+0.16%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: Evercore moved from Hold to Buy on 2026-06-02.
Analyst consensus 19 analysts
Buy
Avg price target 204.19 +40.0%
Price target rangecurrent 145.83
Low180.00
Avg204.19
High225.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | TD Cowen | -- | Buy | 220.00 |
| 2026-11-06 | CCORF | -- | Buy | 205.00 |
| 2026-11-06 | Piper Sandler | -- | Buy | 193.00 |
| 2026-11-06 | BofA Securities | -- | Buy | -- |
| 2026-11-06 | Baird | -- | Buy | 196.00 |
| 2026-11-06 | Stifel | -- | Buy | 180.00 |
| 2026-11-06 | Goldman Sachs | -- | Buy | 210.00 |
| 2026-11-06 | Barclays | -- | Buy | 220.00 |
| 2026-11-06 | RBC Capital | -- | Buy | 200.00 |
| 2026-10-27 | BTIG | -- | Buy | 210.00 |
| 2026-10-22 | Roth MKM | -- | Buy | 200.00 |
| 2026-10-20 | Morgan Stanley | -- | Buy | 200.00 |
| 2026-10-19 | Bernstein | -- | Buy | 210.00 |
| 2026-10-16 | Bernstein | -- | Buy | 210.00 |
| 2026-10-14 | J.P. Morgan | -- | Buy | 195.00 |
| 2026-10-13 | Morgan Stanley | -- | Buy | 200.00 |
| 2026-10-12 | Bernstein | -- | Buy | 210.00 |
| 2026-10-12 | Morgan Stanley | -- | Buy | 200.00 |
| 2026-10-09 | BofA Securities | -- | Buy | 200.00 |
| 2026-10-07 | Barclays | -- | Buy | 220.00 |
| 2026-10-01 | Guggenheim | -- | Buy | 200.00 |
| 2026-09-25 | Bernstein | -- | Buy | 210.00 |
| 2026-09-20 | Goldman Sachs | -- | Buy | 225.00 |
| 2026-09-18 | Barclays | -- | Buy | 200.00 |
| 2026-09-15 | Craig-Hallum | -- | Buy | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-02 | Evercore | Hold → Buy | 160.00 |
| 2026-01-05 | Evercore | Buy → Hold | 105.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | After close | ±19.14% | -1.67% (in line) |
| 2026/Q2 | 2026-07-30 | After close | ±13.74% | +6.33% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±11.67% | +3.73% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±13.88% | -3.08% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±11.83% | +27.87% (beat) |
| 2025/Q2 | 2025-07-30 | After close | ±15.39% | -9.32% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±15.94% | +3.47% (in line) |
| 2024/Q4 | 2025-02-20 | After close | ±19.94% | -9.56% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±13.10% | +13.05% (in line) |
| 2024/Q2 | 2024-08-07 | After close | ±15.26% | -10.87% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±12.97% | +15.07% (beat) |
| 2023/Q4 | 2024-02-22 | After close | ±18.73% | -12.80% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.
Guardant Health discussion 0 comments